Ask the team performing it, and know that colonoscopy may be a more favorable case than other procedures. The reason is the bowel preparation itself. Standard colonoscopy prep involves a clear liquid diet for around 24 hours beforehand, and recent evidence suggests that this diet is doing much of the work that holding the medication was intended to do.<\/p>\n
That does not make the decision yours. It does mean the conversation with your gastroenterologist may go differently than you expect.<\/p>\n
The concern with these medications before sedation is retained stomach contents. Tirzepatide slows gastric emptying, food can remain longer than standard fasting rules assume, and under sedation that raises the risk of aspiration.<\/p>\n
A clear liquid diet addresses that directly. Liquids leave the stomach far faster than solids, so a day without solid food means there is little left to retain regardless of what the medication is doing to emptying rate.<\/p>\n
The evidence for this is reasonably strong and getting stronger. A retrospective study of endoscopy patients found retained gastric contents in about 14 percent of GLP-1 medication users compared with under 4 percent of non-users, a substantial difference, while bowel preparation for same-day lower gastrointestinal procedures markedly reduced that risk.<\/p>\n
A randomized trial at Cleveland Clinic then examined holding versus continuing these medications before upper endoscopy. It was stopped early at interim analysis after crossing a preset boundary, having found a high rate of retained solid food in patients who had not had a clear liquid diet the day before. Among patients who also had a colonoscopy, and therefore followed a clear liquid diet, there were no cases of clinically significant retained gastric volume in either group, whether they held the medication or not.<\/p>\n
The American Society of Anesthesiologists issued consensus-based guidance in 2023 suggesting holding weekly-dosed medications for a week before elective procedures and daily-dosed ones on the day.<\/p>\n
A multisociety clinical practice guidance published in 2024, developed by the American Gastroenterological Association, the American Society for Metabolic and Bariatric Surgery, the International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons, moved toward individual risk assessment rather than a blanket rule. It suggested a liquid diet for at least 24 hours as an option, and noted that where holding is judged necessary, the appropriate duration is unknown.<\/p>\n
Gastroenterology bodies have separately suggested proceeding where a patient has followed standard fasting instructions and has no nausea, vomiting, dyspepsia, or abdominal distension.<\/p>\n
This is the part specific to colonoscopy and rarely discussed.<\/p>\n
Tirzepatide slows motility through the digestive tract, not only the stomach. Some clinicians are concerned this could affect how well the bowel preparation clears, which matters because inadequate prep means a less reliable examination and sometimes a repeat procedure.<\/p>\n
The honest position is that this is being actively studied and not yet settled. A randomized trial comparing holding versus continuing these medications specifically for bowel preparation quality is underway. In the meantime, some units ask patients to extend the clear liquid diet or start the prep earlier.<\/p>\n
Consider this scenario: a patient assumes the whole question is about anesthesia, asks only about aspiration, and is told to carry on as normal. They then have a poor-quality prep and are asked to repeat the procedure in three months. Asking about prep quality as a separate question would have surfaced whether their unit wanted a longer liquid diet.<\/p>\n
Ask both questions: what do you want me to do about the medication, and does it change anything about the prep.<\/p>\n
That is a legitimate answer and increasingly a common one, particularly given the liquid diet you will already be on. It reflects the shift toward risk stratification rather than an oversight.<\/p>\n
If you are told to continue and you then develop nausea or vomiting in the days before, call the unit. Symptoms are exactly what changes the assessment, and they may want to reconsider.<\/p>\n
Follow the instruction, and ask what to do about restarting. For a short hold you will usually resume on your normal day. If the hold runs longer, resuming at your previous dose is not automatic, since tolerance to gastrointestinal effects fades during a break. Our guide on what happens if you stop taking Mounjaro<\/a> covers what a pause involves, and stopping tirzepatide and what the research shows<\/a> covers longer interruptions.<\/p>\n Worth saying plainly. Colonoscopy is a screening and diagnostic procedure with real value, and being on this medication is not a reason to defer it. It is a reason to have a short conversation when you book.<\/p>\n If constipation or other digestive symptoms are part of why the colonoscopy was ordered, mention that you are on this medication, since slowed motility is relevant context for interpreting your symptoms. Our guide on how GLP-1 medications affect your gut health and microbiome<\/a> covers the broader digestive picture.<\/p>\n Ask the team, and expect the answer to be more nuanced than for other procedures, because the clear liquid prep you will already be doing appears to remove most of the retained-contents risk on its own. Ask separately whether it affects prep quality, since that question is still being studied. Report symptoms honestly, follow the written instructions exactly, and do not put the procedure off.<\/p>\nDo not skip the colonoscopy<\/h2>\n
The short version<\/h2>\n